This is an event from the converge study that was reported to the fda under (b)(4) converge safety summary, on august 25th, 2017.A patient (b)(6) year-old female patient underwent a converge procedure on (b)(6) 2017 with no procedural or device complications.The subject experienced excessive bleeding (requiring transfusion) that required prolongation of the existing hospitalization.Per the ct scan, there was question whether minimal soft tissue density posterior to the heart represented minimal posterior mediastinal blood products or edema.The subject was treated with three units of packed red blood cells and two units of fresh frozen plasma.On (b)(6) 2017, the event of excessive bleeding requiring transfusion resolved, patient was discharged home.
|